Navina, a NYC-based healthcare technology company, raised $22m in Series B funding.
The financing, which brought total funding raised to date to $44m, was led by ALIVE Israel HealthTech Fund, with participation from existing investors Grove Ventures, Vertex Ventures Israel, and Schusterman Family Investments. ALIVE’s Managing General Partner, Professor Ari Shamiss, will join Navina’s Board of Directors.
The company intends to use the funds to accelerate growth and adoption of its platform among US physician groups and the enterprise healthcare market, further invest in its AI technology and clinical algorithms, and expand its integration of data sources.
Led by Ronen Lavi, CEO, and Shay Perera, CTO, Navina uses medically-informed AI to turn data into a concise Patient Portrait that gives physicians a deep understanding of their patients’ health status. The system allows for high quality and empathic patient care, resulting in better treatment, reduced missed diagnoses, and a reduced burden on physicians.
FinSMEs
28/10/2022